U.S. markets open in 1 hour 1 minute
  • S&P Futures

    3,722.00
    +52.00 (+1.42%)
     
  • Dow Futures

    29,673.00
    +330.00 (+1.12%)
     
  • Nasdaq Futures

    11,505.75
    +189.50 (+1.67%)
     
  • Russell 2000 Futures

    1,689.40
    +26.90 (+1.62%)
     
  • Crude Oil

    77.88
    +1.17 (+1.53%)
     
  • Gold

    1,645.60
    +12.20 (+0.75%)
     
  • Silver

    18.68
    +0.20 (+1.11%)
     
  • EUR/USD

    0.9644
    +0.0032 (+0.34%)
     
  • 10-Yr Bond

    3.8780
    0.0000 (0.00%)
     
  • Vix

    30.87
    +0.95 (+3.18%)
     
  • GBP/USD

    1.0791
    +0.0108 (+1.01%)
     
  • USD/JPY

    144.4890
    -0.1910 (-0.13%)
     
  • BTC-USD

    20,301.53
    +1,383.94 (+7.32%)
     
  • CMC Crypto 200

    463.69
    +30.59 (+7.06%)
     
  • FTSE 100

    7,042.50
    +21.55 (+0.31%)
     
  • Nikkei 225

    26,571.87
    +140.32 (+0.53%)
     

Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ

·1 min read
Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ

Pfizer Inc. has reached an agreement to buy Global Blood Therapeutics Inc. [s :gbt] in a deal valued at $5.4 billion, the Wall Street Journal reported, citing people familiar with the matter. The news comes after the Journal reported Friday that the two were in advanced talks. Pfizer will pay $68.50- a share in cash for Global Blood Therapeutics, which has one of few approved treatments for sickle-cell disease. The companies are expected to announce the deal later Monday. Global Blood Therapeuti